CoreAge Rx
PartnerBest value on the board: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser.
- Semaglutide
- $149/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
- Not the rock-bottom sticker price — a pure cheapest-first shopper can find lower teaser tiers
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner